SK6342000A3 - 6,11-bridged erythromycin derivatives - Google Patents

6,11-bridged erythromycin derivatives Download PDF

Info

Publication number
SK6342000A3
SK6342000A3 SK634-2000A SK6342000A SK6342000A3 SK 6342000 A3 SK6342000 A3 SK 6342000A3 SK 6342000 A SK6342000 A SK 6342000A SK 6342000 A3 SK6342000 A3 SK 6342000A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
heteroarylene
arylene
group
Prior art date
Application number
SK634-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Yat Sun Or
George Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SK6342000A3 publication Critical patent/SK6342000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK634-2000A 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives SK6342000A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (fr) 1997-10-29 1998-10-29 Derives d'erythromycine a pont 6,11

Publications (1)

Publication Number Publication Date
SK6342000A3 true SK6342000A3 (en) 2000-09-12

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
SK634-2000A SK6342000A3 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Country Status (23)

Country Link
EP (1) EP1027361B1 (fr)
JP (1) JP2001521038A (fr)
KR (1) KR20010031591A (fr)
CN (1) CN1278266A (fr)
AR (1) AR015986A1 (fr)
AT (1) ATE239750T1 (fr)
AU (1) AU1286799A (fr)
BG (1) BG104425A (fr)
BR (1) BR9813317A (fr)
CA (1) CA2307828A1 (fr)
CO (1) CO4990972A1 (fr)
DE (1) DE69814441T2 (fr)
DK (1) DK1027361T3 (fr)
ES (1) ES2198766T3 (fr)
HU (1) HUP0004323A2 (fr)
IL (1) IL134996A0 (fr)
NO (1) NO20002099L (fr)
PL (1) PL340253A1 (fr)
PT (1) PT1027361E (fr)
SK (1) SK6342000A3 (fr)
TR (1) TR200001140T2 (fr)
TW (1) TW486485B (fr)
WO (1) WO1999021864A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
WO2003024986A1 (fr) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. Agents antimicrobiens 6-o-carbamate-11,12-lacto-cetolide
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
WO2003095466A1 (fr) * 2002-05-13 2003-11-20 Enanta Pharmaceuticals, Inc. Derives de l'erythromycine 6,11 bicyclique
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7129221B2 (en) 2002-05-13 2006-10-31 Enanta Pharmaceuticals, Inc. 6,11-bicyclic erythromycin derivatives
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (fr) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. Derives d'erythromycine bicycliques 9-n substitues en c6-c11
WO2005080408A1 (fr) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Composes macrocycliques pontes et procedes de preparation desdits composes
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
WO2018201076A2 (fr) * 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE259823T1 (de) * 1995-11-08 2004-03-15 Abbott Lab Tricyclische erythromycinderivate

Also Published As

Publication number Publication date
CO4990972A1 (es) 2000-12-26
DE69814441T2 (de) 2004-04-08
EP1027361B1 (fr) 2003-05-07
CA2307828A1 (fr) 1999-05-06
CN1278266A (zh) 2000-12-27
BR9813317A (pt) 2000-08-22
NO20002099D0 (no) 2000-04-25
EP1027361A1 (fr) 2000-08-16
TW486485B (en) 2002-05-11
KR20010031591A (ko) 2001-04-16
NO20002099L (no) 2000-06-29
TR200001140T2 (tr) 2001-05-21
AU1286799A (en) 1999-05-17
HUP0004323A2 (hu) 2001-02-28
ES2198766T3 (es) 2004-02-01
BG104425A (bg) 2001-01-31
DK1027361T3 (da) 2003-08-25
PL340253A1 (en) 2001-01-29
AR015986A1 (es) 2001-05-30
ATE239750T1 (de) 2003-05-15
IL134996A0 (en) 2001-05-20
DE69814441D1 (de) 2003-06-12
PT1027361E (pt) 2003-09-30
JP2001521038A (ja) 2001-11-06
WO1999021864A1 (fr) 1999-05-06

Similar Documents

Publication Publication Date Title
US6046171A (en) 6,11-bridged erythromycin derivatives
SK6342000A3 (en) 6,11-bridged erythromycin derivatives
SK285535B6 (sk) 6-O-Substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
CZ303573B6 (cs) 6-O-substituovaný ketolidový derivát erythromycinu, jeho použití, farmaceutická kompozice ho obsahující a zpusob jeho výroby
AU737310B2 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
SK3032000A3 (en) 6,9-bridged erythromycin derivatives
SK286397B6 (sk) 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
US6420535B1 (en) 6-O-carbamate ketolide derivatives
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6946446B2 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
CA2301642A1 (fr) Derives d'erythromycine 3-descladinose 6-o-substituee
EP1181300B1 (fr) Derives ketolide de 6-o-carbamate
JP2003501439A5 (fr)
EP1259923B1 (fr) Agents anti-infectieux utiles contre des souches de bacteries resistant a l'action de plusieurs medicaments
CZ20001394A3 (cs) Erythromycinové deriváty s 6,11-přemostěním
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
SK160299A3 (en) Multicyclic erythromycin derivatives
MXPA00004227A (en) 6,11-bridged erythromycin derivatives
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives
CZ20001045A3 (cs) 3-N-módilikováné 6-O-substituované ketolidové deriváty erytromycinu
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
MXPA00003117A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
CZ407399A3 (cs) Multicyklické deriváty erythromycinu